• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Palantir, Netflix, Domino's Pizza, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today

    7/18/24 10:00:02 PM ET
    $DPZ
    $LLY
    $NFLX
    $PLTR
    Food Distributors
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DPZ alert in real time by email

    On Thursday, major U.S. stock indices were down, with the Dow Jones Industrial Average dropping nearly 1.3% to 40,665.03, the S&P 500 falling almost 0.8% to 5,544.59, and the Nasdaq decreasing 0.7% to 17,871.22.

    Palantir Technologies Inc. (NYSE:PLTR)

    Palantir’s shares rose by 1.49% to close at $28.64, with an intraday high of $29.83 and a low of $28.15. The stock’s 52-week high is $29.83, while the low is $13.68. This rebound came amid a general improvement in tech stocks sentiment, with Wedbush analyst Daniel Ives announcing a new bull-case price target of $50 for the stock.

    Netflix Inc. (NASDAQ:NFLX)

    Netflix’s shares dipped by 0.68% to close at $643.04, despite reporting a 16.8% year-over-year increase in second-quarter revenue. The intraday high and low were $657.04 and $639.17, respectively. The 52-week high stands at $697.49, with a low of $344.73. Netflix reported strong second-quarter financial results, with revenue and earnings per share exceeding expectations and significant growth in paid memberships.

    See Also: No More Getting High On Hemp In America? Multiple States Begin Intoxicating Hemp Crackdown

    Domino’s Pizza, Inc. (NYSE:DPZ)

    Domino’s shares fell sharply by 13.57% to $409.04 after reporting mixed quarterly results. The stock’s intraday high and low were $434.98 and $406.16, respectively. The 52-week high is $542.75, while the low is $330.05. The company reported mixed quarterly results, with second-quarter FY24 sales growth of 7.1% year-over-year to $1.097 billion, missing the analyst consensus estimate of $1.103 billion, and announced a temporary suspension of its guidance metric for global net store growth.

    Eli Lilly and Company (NYSE:LLY)

    Eli Lilly’s stock dropped by 6.26% to close at $848.90. The intraday high was $909.87, and the low was $836.66. The 52-week high and low are $966.1 and $446.56, respectively. The drop might be due to potential continued weakness after recent weight loss data from Roche.

    Tesla, Inc. (NASDAQ:TSLA)

    Tesla’s shares increased slightly by 0.29% to close at $249.23. The intraday high and low were $257.14 and $247.2, respectively. The 52-week high is $299.29, and the low is $138.8. The rise comes despite concerns that a second term for Republican nominee Donald Trump could negatively impact the electric-vehicle giant.

    Photo by WHYFRAME on Shutterstock

    Prepare for the day’s trading with top premarket movers and news by Benzinga.

    Read Next:

    • Chewy Founder, GameStop CEO Ryan Cohen Posts ‘TRUMP’ 665 Times On Elon Musk’s X: Cryptic Message Has Internet Guessing

    This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

    Get the next $DPZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DPZ
    $LLY
    $NFLX
    $PLTR

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    4/14/2026$352.00Sell → Neutral
    UBS
    Tesla Inc.
    $TSLA
    4/13/2026$500.00 → $480.00Outperform
    RBC Capital Mkts
    Netflix Inc.
    $NFLX
    4/6/2026$120.00Neutral → Buy
    Goldman
    Netflix Inc.
    $NFLX
    3/30/2026Mkt Perform
    Citizens
    Netflix Inc.
    $NFLX
    3/24/2026Hold → Buy
    Erste Group
    Netflix Inc.
    $NFLX
    3/18/2026$115.00Buy
    Citigroup
    Eli Lilly and Company
    $LLY
    3/17/2026$850.00Hold → Reduce
    HSBC Securities
    Netflix Inc.
    $NFLX
    3/9/2026$105.00Equal Weight
    Wells Fargo
    More analyst ratings

    $DPZ
    $LLY
    $NFLX
    $PLTR
    SEC Filings

    View All

    SEC Form DEFA14A filed by Netflix Inc.

    DEFA14A - NETFLIX INC (0001065280) (Filer)

    4/16/26 5:08:10 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form DEF 14A filed by Netflix Inc.

    DEF 14A - NETFLIX INC (0001065280) (Filer)

    4/16/26 5:06:21 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Netflix Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - NETFLIX INC (0001065280) (Filer)

    4/16/26 4:01:58 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $DPZ
    $LLY
    $NFLX
    $PLTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lilly confirms date and conference call for first-quarter 2026 financial results announcement

    INDIANAPOLIS, April 16, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will announce its first-quarter 2026 financial results on April 30, 2026. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.  The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.  About LillyLilly is a medicine company turning science into heali

    4/16/26 10:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health

    In ACHIEVE-4, Foundayo met the primary objective of non-inferiority vs. insulin glargine with a 16% lower risk of MACE-4 events and a 23% lower risk of MACE-3 eventsIn a pre-planned analysis, the risk of all-cause death was 57% lower for Foundayo vs. insulin glargine, showing the potential for more comprehensive health benefitsWith these data, Lilly plans to submit Foundayo for the treatment of type 2 diabetes to the U.S. Food and Drug Administration by the end of Q2INDIANAPOLIS, April 16, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ACHIEVE-4 trial evaluating the efficacy and safety of Foundayo (orforglipron), compared to i

    4/16/26 6:45:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Palantir Announces Date of First Quarter 2026 Earnings Release and Webcast

    Palantir Technologies Inc. (NASDAQ:PLTR) announced today that results for its first quarter ended March 31, 2026 will be released on Monday, May 4, 2026, following the close of U.S. markets. Palantir will host a webcast to discuss its results at 5:00 PM ET. A live webcast and replay will be available at investors.palantir.com, and participants can pre-register here. In addition, shareholders can submit and vote on questions by visiting https://app.saytechnologies.com/palantir-2026-q1. About Palantir Technologies Inc. Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com. View source version on businesswire.com: https://w

    4/13/26 4:05:00 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $DPZ
    $LLY
    $NFLX
    $PLTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Neumann Spencer Adam

    4 - NETFLIX INC (0001065280) (Issuer)

    4/3/26 4:07:32 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form 4 filed by Zhu Xiaotong

    4 - Tesla, Inc. (0001318605) (Issuer)

    4/2/26 8:08:52 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Kilgore Leslie J

    4 - NETFLIX INC (0001065280) (Issuer)

    4/2/26 6:02:54 PM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $DPZ
    $LLY
    $NFLX
    $PLTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 7, 2024 - FDA Roundup: May 7, 2024

    For Immediate Release: May 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the treatment of post-traumatic stress disorder. The committ

    5/7/24 4:10:24 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 5, 2023 - FDA Roundup: December 5, 2023

    For Immediate Release: December 05, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, registration opened for the FDA’s virtual Rare Disease Day on Friday, March 1, 2024. This year’s Rare Disease Day is dedicated to patients and health care professionals. Panels will discuss efforts to address the unique challenges with developing treat

    12/5/23 5:00:21 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DPZ
    $LLY
    $NFLX
    $PLTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Musk Elon bought $999,959,042 worth of shares (2,568,732 units at $389.28) (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    9/15/25 6:01:19 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    EVP & CFO Montarce Lucas bought $494,627 worth of shares (715 units at $691.79), increasing direct ownership by 5% to 14,685 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    8/15/25 4:13:02 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Alvarez Ralph bought $500,473 worth of shares (758 units at $660.25) (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    8/14/25 4:12:51 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DPZ
    $LLY
    $NFLX
    $PLTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tesla upgraded by UBS with a new price target

    UBS upgraded Tesla from Sell to Neutral and set a new price target of $352.00

    4/14/26 8:13:10 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    RBC Capital Mkts reiterated coverage on Tesla with a new price target

    RBC Capital Mkts reiterated coverage of Tesla with a rating of Outperform and set a new price target of $480.00 from $500.00 previously

    4/13/26 9:29:55 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Netflix upgraded by Goldman with a new price target

    Goldman upgraded Netflix from Neutral to Buy and set a new price target of $120.00

    4/6/26 8:40:42 AM ET
    $NFLX
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $DPZ
    $LLY
    $NFLX
    $PLTR
    Leadership Updates

    Live Leadership Updates

    View All

    Companies Unveiling Autonomous Defense System Amid Surge Toward $43 Billion Global Market

    Integrated AI system empowers forces to detect, decide, and deploy faster than traditional command structuresNEW YORK, March 30, 2026 /CNW/ -- Market News Updates News Commentary - Autonomous systems are transforming defense operations by enabling militaries to conduct missions with reduced human intervention, increased precision, and faster decision-making cycles. These systems include unmanned aerial vehicles (UAVs), ground robots, maritime platforms, and AI-enabled command systems that support intelligence, surveillance, reconnaissance (ISR), and combat roles. Their integration is largely driven by advancements in artificial intelligence, sensor fusion, and real-time data processing, allo

    3/30/26 8:45:00 AM ET
    $GE
    $KTOS
    $PDYN
    Consumer Electronics/Appliances
    Technology
    Military/Government/Technical
    Industrials

    Lilly to acquire Orna Therapeutics to advance cell therapies

    Orna's in vivo CAR-T pipeline includes potential best-in-class programs to reset the immune system and address B cell-driven autoimmune diseases Acquisition provides a broad platform for long-term innovation in genetic medicine and in vivo cell engineering INDIANAPOLIS and WATERTOWN, Mass., Feb. 9, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient's own body to generate cell

    2/9/26 7:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lambda Appoints Heather Planishek as Chief Financial Officer

    Industry veteran brings deep financial and operational expertise as Lambda accelerates the deployment of AI factories to meet demand from hyperscalers, enterprises, and frontier labs building superintelligence Lambda, the Superintelligence Cloud, today announced the appointment of Heather Planishek as Chief Financial Officer. Planishek brings deep experience scaling high-growth technology companies and will lead Lambda's global finance organization as the company continues to expand its infrastructure footprint and operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251208888678/en/Lambda appoints Heather Planishek as Chi

    12/8/25 8:00:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $DPZ
    $LLY
    $NFLX
    $PLTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Palantir Technologies Inc.

    SC 13G/A - Palantir Technologies Inc. (0001321655) (Subject)

    11/14/24 5:47:09 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Domino's Pizza Inc

    SC 13G/A - DOMINOS PIZZA INC (0001286681) (Subject)

    11/14/24 1:28:31 PM ET
    $DPZ
    Food Distributors
    Consumer Discretionary

    SEC Form SC 13G filed by Domino's Pizza Inc

    SC 13G - DOMINOS PIZZA INC (0001286681) (Subject)

    11/12/24 9:55:15 AM ET
    $DPZ
    Food Distributors
    Consumer Discretionary

    $DPZ
    $LLY
    $NFLX
    $PLTR
    Financials

    Live finance-specific insights

    View All

    Lilly confirms date and conference call for first-quarter 2026 financial results announcement

    INDIANAPOLIS, April 16, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will announce its first-quarter 2026 financial results on April 30, 2026. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.  The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.  About LillyLilly is a medicine company turning science into heali

    4/16/26 10:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Palantir Announces Date of First Quarter 2026 Earnings Release and Webcast

    Palantir Technologies Inc. (NASDAQ:PLTR) announced today that results for its first quarter ended March 31, 2026 will be released on Monday, May 4, 2026, following the close of U.S. markets. Palantir will host a webcast to discuss its results at 5:00 PM ET. A live webcast and replay will be available at investors.palantir.com, and participants can pre-register here. In addition, shareholders can submit and vote on questions by visiting https://app.saytechnologies.com/palantir-2026-q1. About Palantir Technologies Inc. Foundational software of tomorrow. Delivered today. Additional information is available at https://www.palantir.com. View source version on businesswire.com: https://w

    4/13/26 4:05:00 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Scaling Lithium Operations to Meet Surging Global Demand

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Lithium mining is basically riding the same wave as electric vehicles and battery storage, and that wave is getting bigger every year. Demand has been climbing fast because lithium is a core ingredient in rechargeable batteries used in EVs, smartphones, and renewable energy systems. On the supply side, new mines take years to get up and running, so there's often a lag that keeps prices elevated. For investors, that imbalance—strong demand and slower supply growth—is a big part of what's making lithium such an attractive space right now as these Active Companies are looking for opportunities: US Critical Meta

    4/9/26 8:45:00 AM ET
    $ALB
    $LAC
    $SLI
    Major Chemicals
    Industrials
    Metal Mining
    Basic Materials